AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Ascentage Pharma Group International American Depository Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01RJXMB89
15.44▲ 0.52 (3.49%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
14.92
Day's Range
15.21 – 15.44
52-Week Range
14.46 – 35.46
Volume
9,367
Avg Volume
6,952
Share Statistics
Shares Outstanding
Employees
767
Exchange
XNAS
Listed
2025-01-24
Share count as of April 1, 2026

Ascentage Pharma Group International American Depository Shares (AAPG) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Ascentage Pharma Group International American Depository Shares (AAPG)
What is Ascentage Pharma Group International American Depository Shares's Market Cap?
Ascentage Pharma Group International American Depository Shares's Market Cap is $5.8B, based on as-reported figures from SEC (XBRL) filings.
What is Ascentage Pharma Group International American Depository Shares's Enterprise Value?
Ascentage Pharma Group International American Depository Shares's Enterprise Value is $5.9B, based on as-reported figures from SEC (XBRL) filings.
What is Ascentage Pharma Group International American Depository Shares's Price / Sales?
Ascentage Pharma Group International American Depository Shares's Price / Sales is 70.2×, based on as-reported figures from SEC (XBRL) filings.
What is Ascentage Pharma Group International American Depository Shares's EV / Revenue?
Ascentage Pharma Group International American Depository Shares's EV / Revenue is 71.6×, based on as-reported figures from SEC (XBRL) filings.
What is Ascentage Pharma Group International American Depository Shares's EV / EBITDA?
Ascentage Pharma Group International American Depository Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Ascentage Pharma Group International American Depository Shares's Revenue (TTM)?
Ascentage Pharma Group International American Depository Shares's Revenue (TTM) is $82.1M, based on as-reported figures from SEC (XBRL) filings.
What is Ascentage Pharma Group International American Depository Shares's Net Income (TTM)?
Ascentage Pharma Group International American Depository Shares's Net Income (TTM) is -$177.7M, based on as-reported figures from SEC (XBRL) filings.
What is Ascentage Pharma Group International American Depository Shares's EBITDA?
Ascentage Pharma Group International American Depository Shares's EBITDA is -$167.5M, based on as-reported figures from SEC (XBRL) filings.
What is Ascentage Pharma Group International American Depository Shares's Diluted EPS (TTM)?
Ascentage Pharma Group International American Depository Shares's Diluted EPS (TTM) is -0.48, based on as-reported figures from SEC (XBRL) filings.
What is Ascentage Pharma Group International American Depository Shares's EBITDA Margin?
Ascentage Pharma Group International American Depository Shares's EBITDA Margin is -204.0%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · AAPGAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of CNY, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022
REVENUE
Total revenue
Cost of sales
Total cost of sales
Gross profit
Other income and gains
Selling and distribution expenses
Administrative expenses
Research and development expenses
Other expenses
Finance costs
Share of profit/(loss) of a joint venture
LOSS BEFORE TAX
Income tax credit/(expense)
LOSS FOR THE YEAR
Attributable to:
Ordinary equity holders of the Company
Non-controlling interests
LOSS FOR THE YEAR
LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE COMPANY
Basic (in Dollars per share and Yuan Renminbi per share)
Diluted (in Dollars per share and Yuan Renminbi per share)